Skip to main content

Kepler Capital Keeps Their Hold Rating on Sanofi (SNYNF)

Tipranks - Tipranks - Sat Jan 31, 8:00PM CST

In a report released on January 29, Nicolas Pauillac from Kepler Capital maintained a Hold rating on Sanofi, with a price target of €95.00. The company’s shares closed last Thursday at €77.08.

Claim 50% Off TipRanks Premium

Pauillac covers the Healthcare sector, focusing on stocks such as Formycon AG, Sandoz Group Ltd, and COSMO Pharmaceuticals N.V.. According to TipRanks, Pauillac has an average return of 18.2% and a 58.15% success rate on recommended stocks.

In addition to Kepler Capital , Sanofi also received a Hold from Goldman Sachs’s James Quigley in a report issued yesterday. However, on January 29, Bank of America Securities maintained a Buy rating on Sanofi (Other OTC: SNYNF).

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of €110.88 and a one-year low of €76.15. Currently, Sanofi has an average volume of 1.85M.

Read More on SNYNF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).